JPMorgan Chase & Co. 13D and 13G filings for REGENXBIO Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 3:07 pm Purchase |
2024-12-31 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
3,698,862 7.400% |
1,223,216 (+49.41%) |
Filing |
| 2024-10-17 11:42 am Sale |
2024-09-30 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
2,475,646 5.000% |
-1,456,875 (-37.05%) |
Filing |
| 2024-01-25 11:11 am Unchanged |
2023-12-29 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
3,932,521 8.900% |
0 (Unchanged) |
Filing |
| 2024-01-25 11:10 am Purchase |
2023-12-29 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
3,932,521 8.900% |
137,836 (+3.63%) |
Filing |
| 2023-01-27 12:22 pm Sale |
2022-12-30 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
3,794,685 8.700% |
-1,210,269 (-24.18%) |
Filing |
| 2022-01-18 12:59 pm Purchase |
2021-12-31 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
5,004,954 11.700% |
383,112 (+8.29%) |
Filing |
| 2021-11-09 12:23 pm Purchase |
2021-10-29 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
4,621,842 10.800% |
2,089,601 (+82.52%) |
Filing |
| 2021-01-15 1:15 pm Purchase |
2020-12-31 | 13G | REGENXBIO Inc. RGNX |
J P MORGAN CHASE & CO JPM |
2,532,241 6.700% |
2,532,241 (New Position) |
Filing |